Biocon eyes in-licensing opportunities to expand biosimilars portfolio
Biocon is strategically pursuing in-licensing opportunities to bolster its biosimilars portfolio and drive significant margin expansion, leveraging a multi-product launch cycle and a shift towards consolidating its global commercial ...
